Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
13 05 2019
Historique:
received: 18 09 2018
revised: 13 11 2018
accepted: 12 12 2018
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 14 7 2020
Statut: ppublish

Résumé

The Academic Research Consortium (ARC) and the Standardized Data Collection for Cardiovascular Trials Initiative have recently published updated clinical and angiographic endpoint definitions for percutaneous coronary intervention trials. The aim of this document is to provide practical guidance to facilitate and harmonize the implementation of those definitions in randomized trials or registries, as well as to foster consistency among independent adjudication committees. The authors compared the ARC-2 and Standardized Data Collection for Cardiovascular Trials Initiative definitions to identify areas of consistency, complex scenarios, and definitions in need of further standardization. Furthermore, the authors compared the fourth universal definition of myocardial infarction with the ARC-2 definition of myocardial infarction. The Society for Cardiovascular Angiography and Interventions definition of periprocedural myocardial infarction was also compared with the ARC-2 definition and the fourth universal definition of myocardial infarction. An in-depth assessment was done for each individual clinical endpoint to guide clinical investigators on reporting and classifying clinical adverse events. Finally, the authors propose standard streamlined data capture templates for reporting and adjudicating death, myocardial infarction, stroke, revascularization, stent or scaffold thrombosis, and bleeding.

Identifiants

pubmed: 31072504
pii: S1936-8798(18)32554-8
doi: 10.1016/j.jcin.2018.12.031
pii:
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

805-819

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Ernest Spitzer (E)

Cardialysis Core Laboratories and Clinical Trial Management, Rotterdam, the Netherlands; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Eugene McFadden (E)

Department of Cardiology, Cork University Hospital, Cork, Ireland.

Pascal Vranckx (P)

Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, Faculty of Medicine and Life Sciences Hasselt University, Hasselt, Belgium.

Hector M Garcia-Garcia (HM)

Department of Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.

Jonathan H Seltzer (JH)

ACI Clinical, Bala Cynwyd, Pennsylvania.

Claes Held (C)

Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Ton de Vries (T)

Cardialysis Core Laboratories and Clinical Trial Management, Rotterdam, the Netherlands.

Venu Menon (V)

Cardiac Intensive Care Unit, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; C5Research, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.

Kimberly J Brown (KJ)

C5Research, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.

Osama I I Soliman (OII)

Cardialysis Core Laboratories and Clinical Trial Management, Rotterdam, the Netherlands; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Yoshinobu Onuma (Y)

Cardialysis Core Laboratories and Clinical Trial Management, Rotterdam, the Netherlands; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Renato D Lopes (RD)

Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina.

Gregg W Stone (GW)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Columbia University Medical Center, New York, New York.

Donald E Cutlip (DE)

Baim Institute for Clinical Research, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Patrick W Serruys (PW)

National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: patrick.w.j.c.serruys@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH